Detecting treatment-covariate interactions using permutation methods

Statistics in Medicine
Rui WangA Eden Evins

Abstract

The primary objective of a Randomized Clinical Trial usually is to investigate whether one treatment is better than its alternatives on average. However, treatment effects may vary across different patient subpopulations. In contrast to demonstrating one treatment is superior to another on the average sense, one is often more concerned with the question that, for a particular patient, or a group of patients with similar characteristics, which treatment strategy is most appropriate to achieve a desired outcome. Various interaction tests have been proposed to detect treatment effect heterogeneity; however, they typically examine covariates one at a time, do not offer an integrated approach that incorporates all available information, and can greatly increase the chance of a false positive finding when the number of covariates is large. We propose a new permutation test for the null hypothesis of no interaction effects for any covariate. The proposed test allows us to consider the interaction effects of many covariates simultaneously without having to group subjects into subsets based on pre-specified criteria and applies generally to randomized clinical trials of multiple treatments. The test provides an attractive alternative to...Continue Reading

References

Sep 1, 1983·Controlled Clinical Trials·J Shuster, J van Eys
Aug 19, 2004·JAMA : the Journal of the American Medical Association·John MarchUNKNOWN Treatment for Adolescents With Depression Study (TADS) Team
Dec 21, 2004·Biometrics·Xiao Song, Margaret Sullivan Pepe
Sep 13, 2007·JAMA : the Journal of the American Medical Association·David M Kent, Rodney A Hayward
Nov 23, 2007·The New England Journal of Medicine·Rui WangJeffrey M Drazen
Apr 7, 2010·The Canadian Journal of Statistics = Revue Canadienne De Statistique·Rui Wang, Stephen W Lagakos
Apr 14, 2010·Annals of Human Genetics·Petra BůžkováKenneth Rice
Jul 30, 2010·Clinical Trials : Journal of the Society for Clinical Trials·Stephen J RubergYanping Wang
Aug 5, 2011·Statistics in Medicine·Jared C FosterStephen J Ruberg
Sep 29, 2011·Biometrics·Oliver E Lee, Thomas M Braun
Sep 24, 2013·Journal of the American Statistical Association·Lihui ZhaoL J Wei

❮ Previous
Next ❯

Citations

Jul 29, 2016·Biostatistics·Eva PetkovaR Todd Ogden
Dec 17, 2019·JCO Precision Oncology·Susan HalabiSheng Luo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.